Synopsis
0
VMF
0
FDF
0
Australia
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. D-methorphan
2. Dextromethorphan
3. Dextromethorphan Hydrobromide
4. Dextromethorphan Hydrobromide, (+-)-isomer
5. Dextromethorphan Hydrobromide, Monohydrate
6. Dextromethorphan Hydrochloride
7. Dextromethorphan, (+-)-isomer
8. Hydrobromide, Dextromethorphan
9. Hydrochloride, Dextromethorphan
10. L-methorphan
11. Levomethorphan
12. Racemethorphan
1. Dextromethorphan Hydrobromide
2. 125-69-9
3. Antussan
4. Demorphan
5. Dormethan
6. Metrorat
7. Medicon
8. Tusilan
9. Tussade
10. D-methorphan Hydrobromide
11. Romilar
12. Methorate Hydrobromide
13. Dextromethorphan Bromide
14. Dextromethorphan (hydrobromide)
15. Dextromethorphan Hydrobromide Anhydrous
16. Ro 1-5470/5
17. Dextromethorphan Hbr
18. D-3-methoxy-n-methylmorphinan Hydrobromide
19. Z0cg3115fg
20. Benylin Dm
21. (1s,9s,10s)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;hydrobromide
22. Romilar Hydrobromide
23. (9?,13?,14?)-3-methoxy-17-methylmorphinan Hydrobromide
24. Dextroramin P
25. Demorphine
26. Dextrometorphan Hydrobromide
27. Allfen-dm
28. (1s,9s,10r)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;hydrobromide
29. Nsc-756723
30. Demorphan Hydrobromide
31. Einecs 204-750-1
32. Dextromethorphan Polistirex
33. (9alpha,13alpha,14alpha)-3-methoxy-17-methylmorphinan Hydrobromide
34. Unii-z0cg3115fg
35. Canfodion
36. Cosylan
37. Dormetan
38. Hihustan M.
39. Ro 1-5470
40. Dxm Hbr
41. 9-alpha,13-alpha,14-alpha-morphinan, 3-methoxy-17-methyl-, Hydrobromide
42. Schembl121924
43. Morphinan, 3-methoxy-n-methyl-, Hydrobromide, (+)-
44. Chembl1201004
45. Dtxsid60872346
46. Bcp06595
47. Hy-b0620
48. Dextromethorphan Hbr Anhydrous
49. Mfcd00269810
50. Akos022186323
51. Ccg-212567
52. Nsc 756723
53. Dextromethorphan Hydrobromide [mi]
54. Dextromethorphan Hydrobromide [who-dd]
55. Q27294835
56. (9alpha,13alpha,14alpha)-3-methoxy-17-methylmorphinan Hbr
57. 3-methoxy-17-methyl-9.alpha.,13.alpha.,14.alpha.-morphinan Hbr
58. Morphinan, 3-methoxy-17-methyl-, (9alpha,13alpha,14alpha)-, Hydrobromide
59. 3-methoxy-17-methyl-9.alpha.,13.alpha.,14.alpha.-morphinan Hydrobromide
60. 9alpha,13alpha,14alpha-morphinan, 3-methoxy-17-methyl-, Hydrobromide (8ci)
61. Morphinan, 3-methoxy-17-methyl-, (9.alpha.,13.alpha.,14.alpha.)-, Hbr
62. Morphinan, 3-methoxy-17-methyl-, (9.alpha.,13.alpha.,14.alpha.)-, Hydrobromide
63. Morphinan, 3-methoxy-17-methyl-, Hydrobromide (1:1),(9.alpha.,13.alpha.,14.alpha.)-
64. (4bs,8as,9s)-3-methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5h-9,4b-(epiminoethano)phenanthrene Hydrobromide
65. 1887136-04-0
Molecular Weight | 352.3 g/mol |
---|---|
Molecular Formula | C18H26BrNO |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Exact Mass | 351.11978 g/mol |
Monoisotopic Mass | 351.11978 g/mol |
Topological Polar Surface Area | 12.5 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 370 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Delsym |
Active Ingredient | Dextromethorphan polistirex |
Dosage Form | Suspension, extended release |
Route | Oral |
Strength | eq 30mg hbr/5ml |
Market Status | Over the Counter |
Company | Reckitt Benckiser |
2 of 4 | |
---|---|
Drug Name | Dextromethorphan polistirex |
Active Ingredient | Dextromethorphan polistirex |
Dosage Form | Suspension, extended release |
Route | Oral |
Strength | eq 30mg hbr/5ml |
Market Status | Over the Counter |
Company | Tris Pharma |
3 of 4 | |
---|---|
Drug Name | Delsym |
Active Ingredient | Dextromethorphan polistirex |
Dosage Form | Suspension, extended release |
Route | Oral |
Strength | eq 30mg hbr/5ml |
Market Status | Over the Counter |
Company | Reckitt Benckiser |
4 of 4 | |
---|---|
Drug Name | Dextromethorphan polistirex |
Active Ingredient | Dextromethorphan polistirex |
Dosage Form | Suspension, extended release |
Route | Oral |
Strength | eq 30mg hbr/5ml |
Market Status | Over the Counter |
Company | Tris Pharma |
Excitatory Amino Acid Antagonists
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades
Ingredient(s) : Poly L Lactide
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : AceCel is suitable for majority of the directly compressible actives, combines good flow and high compressibility.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral and Parenteral
Application : Fillers, Diluents & Binders
Excipient Details : Lactose is widely used as a filler and diluent in tablets and capsules, and to a more limited extent in lyophilized products and infant formulas.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : HiCel acts as a strong & dry binder. It facilitates low tablet friability & promotes rapid tablet disintegration.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : HiCel CE15 offers a superior mouthfeel with less chalkiness and gritness in chewable tablets and orally disintegrating tablets (ODTs).
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Guar Gum Excipient
Dosage Form : Orodispersible Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Dosage Form : Emulsion
Grade : Oral
Application : Rheology Modifiers
Excipient Details : HiCel MCG is use in oral suspensions as a stabilizer & emulsion prepared with high shear forces. It is a good binder for tablets & excellent stabilizer as well as thickener.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Carboxymethyl cellulose sodium
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : HiCel SMCC has unique combination which result in optimum compaction & superior flow properties.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Direct Compression
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Croscarmellose Sodium
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Dosage Form : Solution
Grade : Oral, Topical
Application : Solubilizers
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Dosage Form : Syrup
Grade : Oral
Brand Name : High Fructose Corn Syrup
Application : Taste Masking
Excipient Details : With unique flavor, it is an important sweetening agent. Since its main ingredient is fructose and glucose, it is called “fructose-glucose syrup”.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : High Fructose Corn Syrup
Dosage Form : Syrup
Grade : Oral
Application : Taste Masking
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Maltitol Excipient
Dosage Form : Syrup
Grade : Oral and Topical
Application : Taste Masking
Dosage Form : Tablet
Grade : Oral & Topical
Application : Taste Masking
Excipients by Applications
Dosage Form : Cream / Lotion / Ointment, Suspension
Grade : Topical
Category : API Stability Enhancers, Thickeners and Stabilizers
Dosage Form : Cream / Lotion / Ointment, Emulsion, Suspension
Grade : Topical, Oral
Category : Emulsifying Agents, Thickeners and Stabilizers
Application : Rheology Modifiers, Thickeners and Stabilizers
Excipient Details : Blanose CMC 7MF is used as a thickener and viscosity modifier in liquid formulations such as suspensions.
Pharmacopoeia Ref : EP, USP/NF
Technical Specs : N/A
Ingredient(s) : Sodium Carboxymethyl Cellulose Excipient
Dosage Form : Cream / Lotion / Ointment, Capsule, Gel, Tablet
Grade : Oral, Topical
Category : API Stability Enhancers, Thickeners and Stabilizers
Dosage Form : Capsule, Suspension, Tablet
Grade : Oral (Pharma Grade)
Category : Fillers, Diluents & Binders, Thickeners and Stabilizers
Application : Fillers, Diluents & Binders, Thickeners and Stabilizers
Excipient Details : KoVidone® K90 acts as a binder for tablets and capsules. It is also used as thickener and stabilizer in liquid dosage forms such as suspension.
Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP
Technical Specs : NA
Ingredient(s) : Polyvinylpyrrolidone K90
Dosage Form : Capsule, Emulsion, Suspension, Syrup, Tablet
Grade : Oral
Category : Solubilizers, Taste Masking, Thickeners and Stabilizers
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Dosage Form : Injectable / Parenteral, Tablet
Grade : Parenteral, Oral
Category : Fillers, Diluents & Binders, Parenteral, Thickeners and Stabilizers
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?